HOLOGRAPHIC NEXT GENERATION GENOMIC DNA SEQUENCING - Trademark Details
Status: 641 - Non-Final Action - Mailed
Serial Number
90024830
Word Mark
HOLOGRAPHIC NEXT GENERATION GENOMIC DNA SEQUENCING
Status
641 - Non-Final Action - Mailed
Status Date
2022-02-04
Filing Date
2020-06-28
Mark Drawing
4000 - Standard character mark
Typeset
Law Office Assigned Location Code
L50
Employee Name
PEISECKI, MARK A
Statements
In Another Form Statement
The mark was first used anywhere in a different form other than that sought to be registered at least as early as 10/20/2006
In Another Form Statement
The mark was first used in commerce in a different form other than that sought to be registered at least as early as 09/08/2007
Goods and Services
DNA analysis services for scientific research purposes; DNA analysis services to determine paternity; DNA screening for scientific research purposes; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genome amplification; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of new technology for others in the field of genetics; Development of new technology for others in the field of genomics; Development of new technology for others in the field of holographic genome sequencing; Development of new technology for others in the field of holographic genome testing; Development of new technology for others in the field of gene splicing; Development of new technology for others in the field of holographic gene splicing; Development of new technology for others in the field of decoding genes; Development of new technology for others in the field of decoding genomes; Development of new technology for others in the field of decoding DNA; Development of new technology for others in the field of holographic genome decoding; Development of new technology for others in the field of holographic genomic decoding; Development of new technology for others in the field of genome decoding holography; Development of new technology for others in the field of genomic DNA sequencing; Development of new technology for others in the field of holographic genomic DNA sequencing; Development of new technology for others in the field of genomic DNA sequencing holography; Drug, alcohol and DNA screening for forensic research purposes; Providing information in the field of plant genetics research resources; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing scientific research information in the field of genetics; Providing scientific research information in the field of genomics; Providing scientific research information in the field of holographic genome sequencing; Providing scientific research information in the field of holographic genome testing; Providing scientific research information in the field of gene splicing; Providing scientific research information in the field of holographic gene splicing; Providing scientific research information in the field of decoding genes; Providing scientific research information in the field of decoding genomes; Providing scientific research information in the field of decoding DNA; Providing scientific research information in the field of holographic genome decoding; Providing scientific research information in the field of holographic genomic decoding; Providing scientific research information in the field of genome decoding holography; Providing scientific research information in the field of genomic DNA sequencing; Providing scientific research information in the field of holographic genomic DNA sequencing; Providing scientific research information in the field of genomic DNA sequencing holography; Scientific research consulting in the field of genetics; Scientific research consulting in the field of genomics; Scientific research consulting in the field of holographic genome sequencing; Scientific research consulting in the field of holographic genome testing; Scientific research consulting in the field of gene splicing; Scientific research consulting in the field of holographic gene splicing; Scientific research consulting in the field of decoding genes; Scientific research consulting in the field of decoding genomes; Scientific research consulting in the field of decoding DNA; Scientific research consulting in the field of holographic genome decoding; Scientific research consulting in the field of holographic genomic decoding; Scientific research consulting in the field of genome decoding holography; Scientific research consulting in the field of genomic DNA sequencing; Scientific research consulting in the field of holographic genomic DNA sequencing; Scientific research consulting in the field of genomic DNA sequencing holography; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of genetics; Scientific research in the field of genomics; Scientific research in the field of holographic genome sequencing; Scientific research in the field of holographic genome testing; Scientific research in the field of gene splicing; Scientific research in the field of holographic gene splicing; Scientific research in the field of decoding genes; Scientific research in the field of decoding genomes; Scientific research in the field of decoding DNA; Scientific research in the field of holographic genome decoding; Scientific research in the field of holographic genomic decoding; Scientific research in the field of genome decoding holography; Scientific research in the field of genomic DNA sequencing; Scientific research in the field of holographic genomic DNA sequencing; Scientific research in the field of genomic DNA sequencing holography; Structural and functional analysis of genomes; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-07-24
Primary Code
042
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
01 - Individual
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Carl Raymond Amos
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 5961750 |
Prior Registration | 5978679 |
Trademark Events
Event Date | Event Description |
2020-07-01 | NEW APPLICATION ENTERED IN TRAM |
2020-07-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-09-16 | ASSIGNED TO EXAMINER |
2020-09-22 | NON-FINAL ACTION WRITTEN |
2020-09-22 | NON-FINAL ACTION E-MAILED |
2020-09-22 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-03-22 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-03-22 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-03-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-04-26 | NON-FINAL ACTION WRITTEN |
2021-04-26 | NON-FINAL ACTION E-MAILED |
2021-04-26 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-11-08 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2021-11-08 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
2022-01-07 | TEAS PETITION TO REVIVE RECEIVED |
2022-01-07 | PETITION TO REVIVE-GRANTED |
2022-01-08 | NOTICE OF REVIVAL - E-MAILED |
2022-02-04 | NON-FINAL ACTION WRITTEN |
2022-02-04 | NON-FINAL ACTION E-MAILED |
2022-02-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |